3:43 PM
 | 
Jun 29, 2017
 |  BC Extra  |  Financial News

Dova rises, Aileron sinks after NASDAQ listings

Rare disease company Dova Pharmaceuticals Inc. (NASDAQ:DOVA) and oncology play Aileron Therapeutics Inc. (NASDAQ:ALRN) each began trading Thursday after pricing IPOs.

Dova gained $2.81 (17%) to $19.81 after raising $75.1 million through the sale of 4.4 million shares at $17 in an IPO underwritten by JPMorgan, Jefferies and Leerink. The offering...

Read the full 245 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >